Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AM-2099 is a voltage-gated sodium channel Nav1.7 inhibitor (IC50: 0.16 μM).
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 447 | 5日内发货 | ||
5 mg | ¥ 747 | 6-8周 | ||
10 mg | ¥ 1,230 | 6-8周 | ||
100 mg | ¥ 5,400 | 6-8周 | ||
1 mL * 10 mM (in DMSO) | ¥ 822 | 6-8周 |
产品描述 | AM-2099 is a voltage-gated sodium channel Nav1.7 inhibitor (IC50: 0.16 μM). |
靶点活性 | Nav1.7 (human):0.16 μM, Nav1.7 (mouse):0.18 μM, Nav1.7 (rat):3.5 μM |
体外活性 | AM-2099 is more than 100-fold selective over Nav1.3, Nav1.4, Nav1.5, and Nav1.8, while lower levels of selectivity are observed against Nav1.1, Nav1.2, and Nav1.6. AM-2099 demonstrates low affinity for hERG (>30 μM) and does not show greater than 50% inhibition against a panel of 100 kinases (1 μM) and a broad CEREP panel (10 μM)[1]. In heterologous cells, comparable inhibition is observed across human, mouse, dog, and cynomolgus monkey NaV1.7 with reduced activity against rat NaV1.7. |
体内活性 | AM-2099 demonstrates a dose-dependent increase in plasma exposure with a concomitant dose-dependent reduction in scratching bouts compared to vehicle-treated animals, with a statistically significant reduction observed at the 60 mg/kg dose[1]. AM-2099 demonstrates a favorable pharmacokinetic profile in rat and dog. In rats AM-2099 shows low total clearance and moderate Vdss and half-life. However, when dosed in dogs AM-2099 shows very low clearance, a low Vdss and long halflife (18 h). |
分子量 | 466.46 |
分子式 | C19H13F3N4O3S2 |
CAS No. | 1443373-17-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 150 mg/mL (321.57 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.1438 mL | 10.719 mL | 21.4381 mL | 53.5952 mL |
5 mM | 0.4288 mL | 2.1438 mL | 4.2876 mL | 10.719 mL | |
10 mM | 0.2144 mL | 1.0719 mL | 2.1438 mL | 5.3595 mL | |
20 mM | 0.1072 mL | 0.536 mL | 1.0719 mL | 2.6798 mL | |
50 mM | 0.0429 mL | 0.2144 mL | 0.4288 mL | 1.0719 mL | |
100 mM | 0.0214 mL | 0.1072 mL | 0.2144 mL | 0.536 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
AM-2099 1443373-17-8 Others AM2099 AM 2099 Inhibitor inhibitor inhibit